Annual update reveals new treatment guidelines for early breast cancer, emphasizing multidisciplinary strategies and prevention.
Optimal management of breast cancer requires a multidisciplinary approach. The interdisciplinary AGO Breast Committee annually issues updated, evidence-based recommendations on prevention, diagnosis, and treatment. The update process follows a predefined methodological framework, including systematic review of relevant recent publications and structured assessment according to the Oxford Levels of Evidence (LoE). The strength of recommendation is determined using the Oxford Grades of Recommendation (GR) in conjunction with the AGO grading system. The most recent update for early and metastatic breast cancer was released in March 2026. This manuscript summarizes the updated recommendations for early breast cancer.
No takes yet. Share an insight, caveat, or question.
Park-Simon et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: